Suchergebnisse - "Vlachopoulos, Charalambos"

PubPharm (12)

1

Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD : A Simulation Study From DA VINCI

enthalten in: Cardiovascular drugs and therapy | 2023

von Vallejo-Vaz, A. | Bray, S. | Villa, G. | +28

2

Extremely high-risk patients with acute coronary syndrome : How "extreme" should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?

enthalten in: Kardiologia polska | 2023

von Rallidis, L. | Tsamoulis, D. | Leventis, I. | +15

3

Twenty-first century epidemiology of dyslipidemia in Greece : EMENO national epidemiological study

enthalten in: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese | 2023

von Stergiou, G. | Ntineri, A. | Menti, A. | +14

4

Emphasizing Study Selection in a Review of Statin Treatment Effects and Low-Density Lipoprotein Cholesterol

enthalten in: JAMA internal medicine | 2022

von Andrikopoulos, G. | Vlachopoulos, C.

CommentOn: JAMA Intern Med. 2022 May 1;182(5):474-481. - PMID 35285850

5

Is it Time for Single-Pill Combinations in Dyslipidemia?

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2022

von Schiele, F. | Pérez de Isla, L. | Arca, M. | +1

6

LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines : Implications for newer lipid-lowering treatments

enthalten in: International journal of cardiology | 2021

von Rizos, C. | Skoumas, I. | Rallidis, L. | +17

7

EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care : the DA VINCI study

enthalten in: European journal of preventive cardiology | 2021

von Ray, K. | Molemans, B. | Schoonen, W. | +28

8

Very high-risk familial hypercholesterolaemia patients in real life : The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors

enthalten in: Atherosclerosis | 2020

von Rallidis, L. | Liberopoulos, E. | Vlachopoulos, C. | +6

CommentOn: Atherosclerosis. 2019 Nov;290:140-205. - PMID 31591002

9

PCSK9 inhibitors in clinical practice : Novel directions and new experiences

enthalten in: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese | 2020

von Rallidis, L. | Skoumas, I. | Liberopoulos, E. | +8

10

Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients

enthalten in: Atherosclerosis | 2020

von Vlachopoulos, C. | Dima, I. | Soulis, D. | +6